European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Next PostHMOs offer protection from tooth decay as formula ingredient You Might Also Like The Global Prebiotic Association Accelerates Expansion, Welcomes Five New Members February 23, 2023 Prebiotics in infant formula could improve learning and memory and alter brain chemistry January 17, 2018 A Randomized Placebo Controlled Clinical Trial to Determine the Impact of Digestion Resistant Starch MSPrebiotic® on Glucose, Insulin, and Insulin Resistance in Elderly and Mid-Age Adults January 23, 2018
Prebiotics in infant formula could improve learning and memory and alter brain chemistry January 17, 2018
A Randomized Placebo Controlled Clinical Trial to Determine the Impact of Digestion Resistant Starch MSPrebiotic® on Glucose, Insulin, and Insulin Resistance in Elderly and Mid-Age Adults January 23, 2018